TaiwanJ Pharmaceuticals Co., Ltd.

TPEX:6549 Stock Report

Market Cap: NT$800.4m

TaiwanJ Pharmaceuticals Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Rich Yuan

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure6.4yrs
CEO ownershipn/a
Management average tenureno data
Board average tenureno data

Recent management updates

Recent updates

Companies Like TaiwanJ Pharmaceuticals (GTSM:6549) Are In A Position To Invest In Growth

Apr 14
Companies Like TaiwanJ Pharmaceuticals (GTSM:6549) Are In A Position To Invest In Growth

Will TaiwanJ Pharmaceuticals (GTSM:6549) Spend Its Cash Wisely?

Dec 29
Will TaiwanJ Pharmaceuticals (GTSM:6549) Spend Its Cash Wisely?

CEO Compensation Analysis

How has Rich Yuan's remuneration changed compared to TaiwanJ Pharmaceuticals's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-NT$28m

Mar 31 2024n/an/a

-NT$17m

Dec 31 2023n/an/a

-NT$6m

Sep 30 2023n/an/a

-NT$38m

Jun 30 2023n/an/a

-NT$71m

Mar 31 2023n/an/a

-NT$82m

Dec 31 2022NT$3mNT$3m

-NT$92m

Compensation vs Market: Insufficient data to establish whether Rich's total compensation is reasonable compared to companies of similar size in the TW market.

Compensation vs Earnings: Insufficient data to compare Rich's compensation with company performance.


CEO

Rich Yuan

6.4yrs

Tenure

NT$3,403,000

Compensation

Mr. Hung-Chang Yuan, also known as Rich, has been General Manager of TaiwanJ Pharmaceuticals Co., Ltd. since June 2018 and also serves as its Director. He is Independent Director of Msscorps Co., Ltd.sinc...